Business
Distribution agreement with US Inter-Technologies
Distribution agreement with US Inter-Technologies.
About this update from Solvonis Therapeutics Plc
[{"type":"text","content":"\n\n\n 26 July 2023\nGraft Polymer (UK) PLC\nCornerstone distribution agreement announced with leading US pet product distributor Inter-Technologies. Inc leveraging compelling opportunities in high growth US veterinary sector\n \nGraft Polymer, (LSE:GPL) a special multi-sector chemicals company offering modified and alloys polymers and bio-polymers solutions for refiners, compounders and processors, announces the signing of a distribution agreement with leading US veterinary products company Inter-Technologies Inc. The agreement is a major step forward in expanding the penetration of the Company's GraftBio products into the Veterinary Food Supplements market in the USA, through Inter-Technologies' five operating subsidiaries in that market.\nThe agreement relates specifically to the distribution of its GraftBio SNEDDS (self-nano emulsifying drug delivery system) products leveraging their unique proposition using the company's patented micelle technology.\n· First move in developing Graft Polymer's US market exposure\n· Evidence of market appetite for the Company's unique, patented technologies\n· Tapping into dynamic growth in the US veterinary market at a time of high consumer spending on pet food and related products\n· Further progress in developing effective partnerships with market leading distributors\n· &...